Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells (Q36659424)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 1997

Language	Label	Description	Also known as
English	Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells	scientific article published on July 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

apoptotic process

1 reference

based on heuristic

inferred from title

6

object named as

E S Vitetta

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

5

object named as

J W Uhr

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Maria-Ana Ghetie

1

object named as

M A Ghetie

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

E M Podar

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Ilgen

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

B E Gordon

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 July 1997

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

94

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

7509-7514

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Antibodies as cytotoxic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Integrins and other adhesion molecules involved in melanocytic tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Immunoconjugates and immunotoxins for therapy of carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Genetically engineered antibody molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Therapy of lymphoma directed at idiotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Engineered humanized dimeric forms of IgG are more effective antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Features of apoptotic cells measured by flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

30 September 2017

Recombinant polymeric IgG: an approach to engineering more potent antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection and properties of resistant mutants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Effect of light chain V region duplication on IgG oligomerization and in vivo efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

p185HER2 signal transduction in breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

An unmodified anticarcinoma antibody, BR96, localizes to and inhibits the outgrowth of human tumors in nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23852

28 June 2018

Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Tumour pharmacokinetics?--we do need to know

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Engineering Antibodies for Therapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Antibody-targeted lymphokine-activated killer cells inhibit liver micrometastases in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Efficient induction of apoptosis in cultured rat glomerular mesangial cells by dimeric monoclonal IgA anti-Thy-1 antibodies

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.14.7509

21 January 2018

Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human B-cell lymphoma growth by CD40 stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A genetically engineered human IgG mutant with enhanced cytolytic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody homodimers: enhanced antitumor activity in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of antibody isotype on passive serotherapy of lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants

1 reference

https://pubmed.ncbi.nlm.nih.gov/9207122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.94.14.7509

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1997PNAS...94.7509G

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36659424&oldid=2107974009"